KR870000071A - 수의 운동을 개선하는 신규약제 조성물 및 그의 생산공정 - Google Patents
수의 운동을 개선하는 신규약제 조성물 및 그의 생산공정 Download PDFInfo
- Publication number
- KR870000071A KR870000071A KR1019860005025A KR860005025A KR870000071A KR 870000071 A KR870000071 A KR 870000071A KR 1019860005025 A KR1019860005025 A KR 1019860005025A KR 860005025 A KR860005025 A KR 860005025A KR 870000071 A KR870000071 A KR 870000071A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- movement
- production process
- composition
- new pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 불활성, 비독성, 약제학적으로 수용할 수 있는 운반체 또는 담체와 혼합되거나 결합하여 유효성분으로써 신경학적으로 활성을 갖는 양의 2,2-비스 페녹시 NN-디메틸에틸아민(또는 메디폭사민) 또는 그의 무기산 또는 유기산 부가염을 갖는 제약조성물.
- 제1항에 있어서, 전체 투여량당 40 내지 200mg의 메디폭사민을 투여함을 특징으로 하는 조성물.
- 제2항에 있어서, 전체 투여량당 40 내지 6mg의 메디폭사민을 투여함을 특징으로 하는 조성물.
- 제1 내지 3항 중 어느 한 항에 있어서, 하루에 200 내지 400mg의 메디폭사민을 투여함을 특징으로 하는 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR85-09572 | 1985-06-24 | ||
| FR8509572A FR2583639B3 (fr) | 1985-06-24 | 1985-06-24 | Nouvelles compositions pharmaceutiques ameliorant les performances psychomotrices et leur procede d'obtention |
| FR8509572 | 1985-06-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR870000071A true KR870000071A (ko) | 1987-02-16 |
| KR940006593B1 KR940006593B1 (ko) | 1994-07-23 |
Family
ID=9320594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019860005025A KR940006593B1 (ko) | 1985-06-24 | 1986-06-24 | 정신 운동 능력을 개선시키는 조성물의 제조방법 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4746679A (ko) |
| EP (1) | EP0212998A3 (ko) |
| JP (1) | JP2523094B2 (ko) |
| KR (1) | KR940006593B1 (ko) |
| AU (1) | AU595208B2 (ko) |
| FR (1) | FR2583639B3 (ko) |
| ZA (1) | ZA864711B (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2589357B3 (fr) * | 1985-11-05 | 1988-01-29 | Rolland Sa A | Nouvelles compositions pharmaceutiques ameliorant l'oxygenation cerebrale a base de diphenoxy dimethylaminoethane et leur procede d'obtention |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5498M (ko) * | 1966-05-18 | 1967-10-30 | ||
| AU593562B2 (en) * | 1985-07-22 | 1990-02-15 | Lipha | N-oxide of NN-dimethyl ethylamine, a process for its production and the pharmaceutical compositions containing it |
| AU592358B2 (en) * | 1985-07-22 | 1990-01-11 | Lipha | Derivatives of diphenoxyethylamine, a process for their production and the pharmaceutical compositions containing the same |
-
1985
- 1985-06-24 FR FR8509572A patent/FR2583639B3/fr not_active Expired
-
1986
- 1986-06-23 AU AU58942/86A patent/AU595208B2/en not_active Ceased
- 1986-06-24 US US06/878,019 patent/US4746679A/en not_active Expired - Lifetime
- 1986-06-24 ZA ZA864711A patent/ZA864711B/xx unknown
- 1986-06-24 KR KR1019860005025A patent/KR940006593B1/ko not_active IP Right Cessation
- 1986-06-24 JP JP61148033A patent/JP2523094B2/ja not_active Expired - Fee Related
- 1986-06-24 EP EP86401389A patent/EP0212998A3/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR940006593B1 (ko) | 1994-07-23 |
| US4746679A (en) | 1988-05-24 |
| AU5894286A (en) | 1988-01-07 |
| FR2583639A1 (fr) | 1986-12-26 |
| EP0212998A2 (fr) | 1987-03-04 |
| JPS6296419A (ja) | 1987-05-02 |
| ZA864711B (en) | 1987-12-30 |
| JP2523094B2 (ja) | 1996-08-07 |
| FR2583639B3 (fr) | 1987-09-25 |
| EP0212998A3 (fr) | 1989-09-27 |
| AU595208B2 (en) | 1990-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8505112D0 (sv) | Novel pharmacological compounds | |
| IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
| SE8303531D0 (sv) | Farmaceutisk komposition | |
| KR920007629A (ko) | SALMe염, 5-MTHF 및 5-FTHF 중에서 선택된 화합물 적어도 1개를 유효성분으로서 함유하여 AIDS환자의 신경학적 질환치료시 활성을 나타내는 약제학적 조성물 | |
| DE3587928D1 (de) | N-Acetylneuraminsäure und deren Salze enthaltende Expektorantien. | |
| KR900007424A (ko) | 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물 | |
| FR2598320B1 (fr) | Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques | |
| FR2581873B1 (fr) | Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide | |
| KR870000071A (ko) | 수의 운동을 개선하는 신규약제 조성물 및 그의 생산공정 | |
| ES8607728A1 (es) | Procedimiento de preparacion de una nueva composicion anti- biotica sinergetica, de uso veterinario | |
| JPS5551019A (en) | Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof | |
| KR870001144A (ko) | Nn-디메틸에틸옥사이드가 함유된 약제조성물 및 그의 생산방법 | |
| KR880012518A (ko) | 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물 | |
| ES2053683T3 (es) | Forma de medicamento de aplicacion oral para el tratamiento de la hipertension una vez al dia con hidrocloruro de diltiazem. | |
| KR870001153A (ko) | 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법 | |
| KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
| KR880000094A (ko) | 위염치료제 | |
| IT1260996B (it) | Fiala a soluzione per infusione di acido tiottico in forma di sale idrosolubile dell'acido tiottico. | |
| KR890001549A (ko) | 위염 치료제 | |
| KR870005642A (ko) | 디플루니살과 트로메타민의 혼합물 | |
| KR890007737A (ko) | 진토작용을 하는 약제 | |
| KR900013959A (ko) | γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물 | |
| KR890001567A (ko) | 디플루니살 및 트로메타민-함유 조성물 | |
| ES8105284A1 (es) | Procedimiento para preparar indolinas. | |
| KR870004702A (ko) | 뇌의 산소반응을 개량하는 제약조성물 및 그의 제법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E902 | Notification of reason for refusal | ||
| G160 | Decision to publish patent application | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20030708 Year of fee payment: 10 |
|
| LAPS | Lapse due to unpaid annual fee |